{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/stroke-tia/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"e606f403-4b76-5e30-a38d-6aa4b6e3b4b1","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 18cae520-417a-4917-b596-650984843df5 --><h2>Update</h2><!-- end field 18cae520-417a-4917-b596-650984843df5 -->","summary":null,"htmlStringContent":"<!-- begin item d6abd9b4-2149-4e85-929f-da5abd7e2f93 --><!-- end item d6abd9b4-2149-4e85-929f-da5abd7e2f93 -->","topic":{"id":"f543bb01-4edc-57a6-ba31-aaa6b6b6e6e8","topicId":"63954e32-591d-4f33-bcbb-3fdecfc69796","topicName":"Stroke and TIA","slug":"stroke-tia","lastRevised":"Last revised in August 2020","chapters":[{"id":"3690cd7d-0a6b-548a-a527-b276c3924bab","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"aef0c419-4ee2-52b6-b781-c8afa9a11104","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f8baebfc-07d7-5c4a-8d95-4d2bf1f42c38","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3fa3210c-0be8-5167-adb3-6c05aaef00bc","slug":"changes","fullItemName":"Changes"},{"id":"e606f403-4b76-5e30-a38d-6aa4b6e3b4b1","slug":"update","fullItemName":"Update"}]},{"id":"fe337d01-2447-58d3-93e8-a6b09a4920d4","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"08277b76-a6c4-566a-a594-131c32067735","slug":"goals","fullItemName":"Goals"},{"id":"acf4fa85-325c-5018-8bc2-9d877522bf6f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"18bc44dc-3e6b-58ae-9d3c-abca76b13c16","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4eb59f42-29b3-56e1-993f-1ce8ab7b2969","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"08107877-662b-59e6-a30a-b21e19250f23","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ff061807-ab05-5af8-8dd4-01db71526d0f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a0b319c1-8df3-5206-93ce-302f6b981e82","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a0bcd779-defb-50a7-86f6-ab4b2c701ac7","slug":"definition","fullItemName":"Definition"},{"id":"c40d717d-0b67-5cb2-b86c-c67045400115","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"d1569ff2-5da1-51a0-9720-75ad88c0ad86","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"ee8fc150-6899-5c75-a0d0-6241055dfd09","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d5730239-5d67-598b-b9d1-f339079de3eb","slug":"complications","fullItemName":"Complications"},{"id":"9b730ca3-d3ee-552b-8145-f6eadf244a63","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"caea5ae7-0be8-5c7c-8bef-7162c7171e9d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"67902a93-a36b-58c6-a67a-3eb89654460c","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"2bc808d1-f905-575d-90b2-8481eb492905","slug":"assessment","fullItemName":"Assessment"},{"id":"6562a8bf-1396-58ba-b1b9-a1914e4adebe","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"2d634696-3361-5fd3-b676-609f3c31c2f1","fullItemName":"Management","slug":"management","subChapters":[{"id":"1baf2362-0da4-599f-8f9a-12d0124253a0","slug":"suspected-acute-stroke","fullItemName":"Scenario: Suspected acute stroke"},{"id":"15af1682-8287-57f9-90f1-954c1f71792e","slug":"suspected-transient-ischaemic-attack","fullItemName":"Scenario: Suspected transient ischaemic attack"},{"id":"91d820f4-4249-556c-99e2-4ac86d3ebd2a","slug":"secondary-prevention-following-stroke-tia","fullItemName":"Scenario: Secondary prevention following stroke and TIA"},{"id":"84ca3884-d693-5209-b048-6ff53b4ae2be","slug":"management-of-long-term-complications-of-stroke","fullItemName":"Scenario: Management of long term complications of stroke"}]},{"id":"30a83b67-7804-5b41-a647-98d32dce018a","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"ebfe1dbe-0d9c-5a26-82b4-4d0a308a19ac","slug":"antiplatelet-treatment","fullItemName":"Antiplatelet treatment"}]},{"id":"279444c7-61df-5f92-b512-c703ae6cb9fb","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8ef8b6ac-1d47-5038-b4d7-4d77faf1a823","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"72590587-c86f-5da1-b397-b7e6cc757702","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7ba85ca6-985e-5af5-b223-0c27f7066797","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b322154e-a2d3-59d1-a7b2-d70b4e7812da","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"18f7eefe-52bd-5ad8-a39c-b96d270599ff","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8fed8545-5194-53a4-b547-2d6a402857f5","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"216e65b7-f638-5b35-ad86-30270fbea649","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"f8baebfc-07d7-5c4a-8d95-4d2bf1f42c38","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"d941d1bb-0666-5834-b24c-fbcb557c6eca","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 407a7c3d-f817-43a4-a394-a0c7eb964808 --><h3>New evidence</h3><!-- end field 407a7c3d-f817-43a4-a394-a0c7eb964808 -->","summary":null,"htmlStringContent":"<!-- begin item e3300c5a-04b9-491f-aaa2-bd1a3ebdfc55 --><!-- begin field a3b793f2-e4f7-40fe-b8c1-4a2a267ce44c --><h3>Evidence-based guidelines</h3><!-- end field a3b793f2-e4f7-40fe-b8c1-4a2a267ce44c --><!-- begin field 1fe86f20-9811-4557-ab5a-8daec4682ba7 --><ul><li>SIGN (2017) <em>Cardiac rehabilitation</em>. Scottish Intercollegiate Guidelines Network. <a data-hyperlink-id=\"76f815a4-a184-4029-881d-a8f701605003\" href=\"https://www.sign.ac.uk/\">www.sign.co.uk</a> [<a data-hyperlink-id=\"be0776d6-2593-416c-9ae5-a8f701605024\" href=\"http://www.sign.ac.uk/sign-150-cardiac-rehabilitation.html\">Free Full-text</a>]</li><li>SIGN (2017) <em>Risk estimation and the prevention of cardiovascular disease</em>. Scottish Intercollegiate Guidelines Network. <a data-hyperlink-id=\"0c52aee2-6db4-4601-8be6-a8f701605060\" href=\"https://www.sign.ac.uk/\">www.sign.co.uk</a> [<a data-hyperlink-id=\"e1fd7b8d-151e-457a-a46f-a8f701605065\" href=\"http://www.sign.ac.uk/sign-149-risk-estimation-and-the-prevention-of-cardiovascular-disease.html\">Free Full-text</a>]</li><li>AHA/ASA (2018) <em>2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association</em>. AHA/ASA. [<a data-hyperlink-id=\"dcd176da-e431-4685-9181-a8f7016050ea\" href=\"http://stroke.ahajournals.org/content/early/2018/01/23/STR.0000000000000158\">Free Full Text</a>]</li><li>Mulder, M. J., Jansen, I. V., Goldhoorn, R-B. (2018) <em>Time to endovascular treatment and outcome in acute ischemic stroke: MR CLEAN registry results.</em> Circulation. [<a data-hyperlink-id=\"4c6e61bf-ea2a-41d4-bd46-a8f701605345\" href=\"http://circ.ahajournals.org/content/early/2018/03/14/CIRCULATIONAHA.117.032600\">Free Full-text</a>]</li><li>Zerna, C., et al (2018)<em> Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke. </em>The Lancet. <a href=\"https://www.thelancet.com/\" data-hyperlink-id=\"d3ecc078-555b-473c-a6ad-a97700e34611\">www.thelancet.com</a> [<a href=\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31874-9/fulltext\" data-hyperlink-id=\"891d1148-e52a-4747-940d-a97700e34d18\">Free Full-text</a>]</li><li>Pandian, J., et al (2018) Prevention of stroke: a global perspective. The Lancet. <a href=\"https://www.thelancet.com/\" data-hyperlink-id=\"83dbd869-de42-426d-90b9-a97700e35718\">www.thelancet.com</a> [<a href=\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31269-8/fulltext\" data-hyperlink-id=\"161af5c6-d7ac-486a-b02a-a97700e36483\">Free Full-text</a>]</li></ul><!-- end field 1fe86f20-9811-4557-ab5a-8daec4682ba7 --><!-- begin field 9f195045-a6c4-4da6-b2f9-eb8989d9e309 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field 9f195045-a6c4-4da6-b2f9-eb8989d9e309 --><!-- begin field 4dedce1f-7ada-4eea-bfc6-a1739a1f5c67 --><p>No new HTAs since 1 January 2017.</p><!-- end field 4dedce1f-7ada-4eea-bfc6-a1739a1f5c67 --><!-- begin field 206215fc-2065-4838-aeca-51ccb58eea1d --><h3>Economic appraisals</h3><!-- end field 206215fc-2065-4838-aeca-51ccb58eea1d --><!-- begin field e42cbcd5-3d6f-41ad-9090-73a4cba7e47a --><p>No new economic appraisals relevant to England since 1 January 2017.</p><!-- end field e42cbcd5-3d6f-41ad-9090-73a4cba7e47a --><!-- begin field e41651d5-47dd-452a-bce0-5e337cba0f55 --><h3>Systematic reviews and meta-analyses</h3><!-- end field e41651d5-47dd-452a-bce0-5e337cba0f55 --><!-- begin field 9d49e786-883e-4112-9d45-74d551aa28d8 --><ul><li>The Lancet (2018) Sex differences in the evaluation and treatment of acute ischaemic stroke. The Lancet. <a data-hyperlink-id=\"35fe8d49-7686-4b7c-99c0-a90b00b1bc50\" href=\"https://www.thelancet.com/\">www.thelancet.com</a> [<a data-hyperlink-id=\"c37f585f-942a-49f3-9bca-a90b00b1c3f8\" href=\"https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30201-1/fulltext\">Free Full-text</a>]</li><li>Zonneveld, T., et al (2018) Blood pressure‐lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack. The Cochrane Library. <a data-hyperlink-id=\"4d0c60de-599f-482c-af84-a96c009733d4\" href=\"https://www.cochranelibrary.com/\">www.cochranelibrary.com</a> [<a data-hyperlink-id=\"47884f97-3f79-4235-84f6-a96c009734a9\" href=\"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007858.pub2/full\">Free Full-text</a>]</li><li>Feigin, V., Nguyen, G., Cercy, K., et al (2018) <em>Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016. </em>The New England Journal of Medicine. <a data-hyperlink-id=\"15a56881-5b67-4755-a5cc-a9d700b6e20b\" href=\"https://www.nejm.org/\">www.nejm.org</a> [<a data-hyperlink-id=\"79aa73c7-54f6-4d4b-b56c-a9d700b6e287\" href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa1804492\">Free Full-text</a>]</li><li>Seminog, O., Scarborough, P., Wright, L., et al (2019) <em>Determinants of the decline in mortality from acute stroke in England: linked national database study of 795 869 adults. </em>The British Medical Journal. <a data-hyperlink-id=\"2972aec2-6c08-4d52-97e5-aa570093d8dc\" href=\"https://www.bmj.com/\">www.bmj.com</a> [<a data-hyperlink-id=\"9209d806-88c0-4b76-916e-aa570093d8ee\" href=\"https://www.bmj.com/content/365/bmj.l1778\">Free Full-text</a>]</li><li>Mehra, M., Vaduganathan, M., Fu, M., et al. (2019) <em>A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. European Society of Cardiology. </em><a data-hyperlink-id=\"08ada31b-f70c-497f-898d-aa8100e075e4\" href=\"https://academic.oup.com/journals\">www.academic.oup.com</a> [<a data-hyperlink-id=\"29821105-664f-4c0f-9134-aa8100e076b6\" href=\"https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehz427/5522950\">Free Full-text</a>]</li><li>Jame, S. and Barnes, G. (2019) <em>Stroke and thromboembolism prevention in atrial fibrillation</em>. Heart BMJ. <a data-hyperlink-id=\"35c83b2e-d7ef-43fc-8ef2-aae200aa7b77\" href=\"https://heart.bmj.com/\">www.heart.bmj.com</a> [<a data-hyperlink-id=\"be127b75-ceae-414b-a272-aae200aa7b93\" href=\"https://heart.bmj.com/content/early/2019/09/18/heartjnl-2019-314898\">Abstract</a>]</li><li>Phipps, M., and Cronin, C. (2020) <em>Management of acute ischemic stroke. </em>The BMJ. <a href=\"https://www.bmj.com/\" data-hyperlink-id=\"c52e8499-54b2-40cb-a5cc-ab6d00c0cd4f\">www.bmj.com</a> [<a href=\"https://www.bmj.com/content/368/bmj.l6983\" data-hyperlink-id=\"afa0d504-0189-4e34-a13e-ab6d00c0cd67\">Free Full-text</a>]</li></ul><!-- end field 9d49e786-883e-4112-9d45-74d551aa28d8 --><!-- begin field c7285bfc-edae-4e74-b538-371da2bedca0 --><h3>Primary evidence</h3><!-- end field c7285bfc-edae-4e74-b538-371da2bedca0 --><!-- begin field 23dfda2a-c618-432f-a24e-2b1bd1447b77 --><ul><li>Johnston, S. et al. (2018) <em>Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA</em>. The New England Journal of Medicine. <a href=\"https://www.nejm.org/\" data-hyperlink-id=\"b7629211-a3ea-45fe-8173-a8f7015abb5b\">www.nejm.org</a> [<a href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa1800410#article_citing_articles\" data-hyperlink-id=\"8d3ee29a-d91d-42b9-be53-a8f7015abd15\">Free Full-text</a>]</li></ul><!-- end field 23dfda2a-c618-432f-a24e-2b1bd1447b77 --><!-- end item e3300c5a-04b9-491f-aaa2-bd1a3ebdfc55 -->","subChapters":[]},{"id":"a1a776e4-7a7d-5a41-ae12-d13d8de9e00f","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field dac28e32-e455-4e31-9e24-0e8778ca9106 --><h3>New policies</h3><!-- end field dac28e32-e455-4e31-9e24-0e8778ca9106 -->","summary":null,"htmlStringContent":"<!-- begin item 3306548d-f7ad-436d-b088-3e89be760a26 --><!-- begin field b9cdafb7-fd6a-4b1b-bb7f-f4816f1c32af --><p>No new national policies or guidelines since 1 January 2017.</p><!-- end field b9cdafb7-fd6a-4b1b-bb7f-f4816f1c32af --><!-- end item 3306548d-f7ad-436d-b088-3e89be760a26 -->","subChapters":[]},{"id":"a1705ac0-d72d-5720-90c8-b0f7d37c1d69","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field 522ab06b-6325-4ac5-9805-1381086ad7f7 --><h3>New safety alerts</h3><!-- end field 522ab06b-6325-4ac5-9805-1381086ad7f7 -->","summary":null,"htmlStringContent":"<!-- begin item 5b53c3be-fe0d-416d-9fec-4676c86624fc --><!-- begin field 23794da3-4404-4811-a9b4-98ddd2806b76 --><p>No new safety alerts since 1 January 2017.</p><!-- end field 23794da3-4404-4811-a9b4-98ddd2806b76 --><!-- end item 5b53c3be-fe0d-416d-9fec-4676c86624fc -->","subChapters":[]},{"id":"25473c57-91d7-556f-9fab-ca0266c7f512","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 129f43e2-bafa-420b-ac5b-fb946b2e68fb --><h3>Changes in product availability</h3><!-- end field 129f43e2-bafa-420b-ac5b-fb946b2e68fb -->","summary":null,"htmlStringContent":"<!-- begin item 0ba4dade-6724-47c7-a0f8-7d96a0ab41b7 --><!-- begin field 45948bc3-c29a-40bc-97c0-4155cbc8904d --><p>No changes to product availability since 1 January 2017.</p><!-- end field 45948bc3-c29a-40bc-97c0-4155cbc8904d --><!-- end item 0ba4dade-6724-47c7-a0f8-7d96a0ab41b7 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}